AxioMed Completes 2-Year Follow-up for Freedom Lumbar Disc

By Julie A. Vetalice

AxioMed has completed collection and analysis of 2-year follow-up data in its U.S. Investigational Device Exemption clinical study of the Freedom viscoelastic lumbar disc.

The device received CE Mark approval in 2009, and has been used to treat >500 patients with follow-up exceeding 7 years. The company is seeking FDA Premarket Approval of the Freedom lumbar disc replacement within 2017.

Sources: AxioMed LLC; ORTHOWORLD Inc.

Product Labels: Lumbar Spine

Tags: Trial/Study